Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

  • Y. K. Kang
  • , C. Yoo
  • , B. Y. Ryoo
  • , J. J. Lee
  • , E. Tan
  • , I. Park
  • , J. H. Park
  • , Y. J. Choi
  • , J. Jo
  • , J. S. Ryu
  • , M. H. Ryu

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science